ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.72
0.56%
US Tech 100
17,610.00
0.04%
S&P 500
5,200.86
0.25%
US Dollar vs CAD
1.36892
-0.28%
Bitcoin
62,420.95
2.02%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Oaktree Acquisition Corp II (OACB)

  7. Oaktree Acquisition Corp II (OACB) News

OACB

Oaktree Acquisition Corp... (OACB)

Oaktree Acquisition Corp II
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:OACB
DateTimeSourceHeadlineSymbolCompany
06/15/202210:36AMEdgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NYSE:OACBOaktree Acquisition Corp II
06/09/20226:10AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NYSE:OACBOaktree Acquisition Corp II
06/08/20228:16PMBusiness WireAlvotech und Oaktree Acquisition Corp. II melden Zustimmung der Aktionäre zum UnternehmenszusammenschlussNYSE:OACBOaktree Acquisition Corp II
06/08/20224:54AMBusiness WireAlvotech et Oaktree Acquisition Corp. II annoncent l'approbation des actionnaires pour le regroupement d'entreprisesNYSE:OACBOaktree Acquisition Corp II
06/07/20223:00PMBusiness WireAlvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business CombinationNYSE:OACBOaktree Acquisition Corp II
06/03/20224:29PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:OACBOaktree Acquisition Corp II
06/03/20224:17PMBusiness WireOaktree Acquisition Corp. II Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with AlvotechNYSE:OACBOaktree Acquisition Corp II
05/31/20224:19PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:OACBOaktree Acquisition Corp II
05/24/20226:24AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NYSE:OACBOaktree Acquisition Corp II
05/24/20226:00AMBusiness WireAlvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®NYSE:OACBOaktree Acquisition Corp II
05/17/20228:00AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:OACBOaktree Acquisition Corp II
05/16/20222:08PMEdgar (US Regulatory)Quarterly Report (10-q)NYSE:OACBOaktree Acquisition Corp II
05/16/20227:07AMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NYSE:OACBOaktree Acquisition Corp II
05/16/20227:00AMBusiness WireAlvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®NYSE:OACBOaktree Acquisition Corp II
05/11/20227:00AMBusiness WireAlvotech, Global Biotech Company, and Oaktree Acquisition Corp. II Announce June 7, 2022 Extraordinary General Meeting to Approve Business CombinationNYSE:OACBOaktree Acquisition Corp II
05/10/20225:34PMEdgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NYSE:OACBOaktree Acquisition Corp II
04/22/20223:31PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:OACBOaktree Acquisition Corp II
04/20/20224:00PMBusiness WireAlvotech améliore son accès aux capitaux et optimise son processus d’entrée en bourse, prévue sur le NASDAQNYSE:OACBOaktree Acquisition Corp II
04/20/202211:45AMBusiness WireAlvotech verbessert Zugang zu Kapital und ebnet Weg für erwartete NASDAQ-NotierungNYSE:OACBOaktree Acquisition Corp II
04/20/20227:15AMBusiness WireAlvotech migliora l'accesso al capitale e semplifica il percorso verso la prevista quotazione in Borsa al NASDAQNYSE:OACBOaktree Acquisition Corp II
04/19/20225:00PMBusiness WireAlvotech Improves Access to Capital and Streamlines Path to Expected Public Listing on NASDAQ Stock ExchangeNYSE:OACBOaktree Acquisition Corp II
04/19/20224:26PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NYSE:OACBOaktree Acquisition Corp II
04/18/20224:12PMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:OACBOaktree Acquisition Corp II
04/08/20229:01AMBusiness WireアルヴォテックとSTADA、アッヴィとの欧州特許紛争を解決してHumira®のクエン酸フリー高濃度バイオシミラーHUKYNDRA®（AVT02）発売への道を開くNYSE:OACBOaktree Acquisition Corp II
04/06/20228:15PMBusiness WireAlvotech et STADA ouvrent la voie au lancement de HUKYNDRA® (AVT02), un biosimilaire de l'Humira® haute concentration sans citrate, en réglant le litige de brevet européen qui les opposait à AbbVieNYSE:OACBOaktree Acquisition Corp II
04/06/20225:21PMBusiness WireAlvotech und STADA ebnen durch Beilegung des europäischen Patentstreits mit AbbVie den Weg für die Markteinführung von HUKYNDRA®(AVT02), einem zitratfreien, hochkonzentrierten Biosimilar zu Humira®NYSE:OACBOaktree Acquisition Corp II
04/06/20226:51AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:OACBOaktree Acquisition Corp II
04/06/20226:00AMBusiness WireAlvotech and STADA Pave Way to Launching HUKYNDRA®(AVT02), a Citrate-free, High-concentration Biosimilar to Humira® by Resolving European Patent Dispute With AbbVieNYSE:OACBOaktree Acquisition Corp II
03/23/20223:20PMEdgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NYSE:OACBOaktree Acquisition Corp II
03/14/20226:10AMBusiness Wireアルヴォテックがアッヴィとの米国特許・企業秘密紛争を解決し、Humira®向けにアルヴォテックが提案中の高濃度バイオシミラー（AVT02）の米国での権利を確保NYSE:OACBOaktree Acquisition Corp II
 Showing the most relevant articles for your search:NYSE:OACB

Your Recent History

USOTC
BMXI
Brookmount Explorations (PK)
USOTC
RONN
Ronn Motor (PK)
NASDAQ
HOLO
MicroCloud Hologram
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
KEGS
1812 Brewing (PK)
USOTC
AHRO
Authentic (CE)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
KGKG
Kona Gold Beverage (PK)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
TKMO
Tekumo (PK)
USOTC
FLES
Auto Parts 4Less (PK)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
CEOS
CeCors (PK)
USOTC
INQD
Indoor Harvest (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved